NL6815755A - - Google Patents

Info

Publication number
NL6815755A
NL6815755A NL6815755A NL6815755A NL6815755A NL 6815755 A NL6815755 A NL 6815755A NL 6815755 A NL6815755 A NL 6815755A NL 6815755 A NL6815755 A NL 6815755A NL 6815755 A NL6815755 A NL 6815755A
Authority
NL
Netherlands
Application number
NL6815755A
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NL6815755A publication Critical patent/NL6815755A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
NL6815755A 1967-11-24 1968-11-05 NL6815755A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT1064767A AT280290B (de) 1967-11-24 1967-11-24 Verfahren zur Herstellung von neuen 1-Phenyl-4-alkyl-3H-1,4-benzodiazepin-2,5-[1H,4H]-dionen

Publications (1)

Publication Number Publication Date
NL6815755A true NL6815755A (xx) 1969-05-28

Family

ID=3623762

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6815755A NL6815755A (xx) 1967-11-24 1968-11-05

Country Status (13)

Country Link
AT (1) AT280290B (xx)
BE (1) BE724364A (xx)
BR (1) BR6804236D0 (xx)
CH (1) CH523265A (xx)
DE (1) DE1810423B2 (xx)
DK (1) DK124950B (xx)
ES (2) ES360410A1 (xx)
FR (2) FR1593335A (xx)
GB (1) GB1173540A (xx)
IE (1) IE32504B1 (xx)
IL (1) IL31146A (xx)
NL (1) NL6815755A (xx)
SE (1) SE356979B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914216A (en) * 1962-12-18 1975-10-21 Boehringer Sohn Ingelheim 1-Phenyl-3H-1,4-benzodiazepine-2,5-(1H,4H)-diones
DE2117438A1 (de) * 1971-04-08 1972-10-19 CH. Boehringer Sohn, 6507 Ingelheim Neue substituiert 1,3-Dihydro-2H-1 ^-benzodiazepine^-one
BE793460A (fr) * 1971-12-29 1973-06-28 Boehringer Sohn Ingelheim Nouvelles 1-aryl-3h,1,4-benzodiazepine-2,5-(1h
US7572788B2 (en) 1999-04-30 2009-08-11 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US7276348B2 (en) 1999-04-30 2007-10-02 Regents Of The University Of Michigan Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
DE60042425D1 (de) * 1999-04-30 2009-07-30 Univ Michigan Verwendung von Benzodiazepinen zur Behandlung von autoimmunischen Krankheiten, Entzündungen, Neoplasien, viralen Infektionen und Atherosklerosis
US20060025388A1 (en) 1999-04-30 2006-02-02 Glick Gary D Compositions and methods relating to novel compounds and targets thereof
US7691582B2 (en) 2002-09-27 2010-04-06 The Regents Of The University Of Michigan Methods of secretory vimentin detection and modulation
AU2006203946B2 (en) 2005-01-03 2009-07-23 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
WO2007053193A2 (en) 2005-06-01 2007-05-10 The Regents Of The University Of Michigan Unsolvated benzodiazepine compositions and methods
AU2006308655B2 (en) 2005-11-01 2010-09-23 The Regents Of The University Of Michigan Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
US7759338B2 (en) 2006-04-27 2010-07-20 The Regents Of The University Of Michigan Soluble 1,4 benzodiazepine compounds and stable salts thereof
WO2007146167A1 (en) 2006-06-09 2007-12-21 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
WO2008112553A1 (en) 2007-03-09 2008-09-18 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
EP2146722A4 (en) * 2007-05-10 2011-08-03 Amr Technology Inc ARYL AND HETEROARYL SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND THEIR USE FOR BLOCKING THE RECOVERY OF NOREPINEPHRIN, DOPAMINE AND SEROTONINE
WO2009036175A2 (en) 2007-09-14 2009-03-19 The Regents Of The University Of Michigan F1f0-atpase inhibitors and related methods
RU2010122902A (ru) 2007-11-06 2011-12-20 Дзе Риджентс оф дзе Юниверсити оф Мичиган (US) Бензодиапениноновые соединения, применимые в лечении кожных состояний
JP5567573B2 (ja) 2008-09-11 2014-08-06 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン アリールグアニジンf1f0−atpアーゼ阻害剤およびそれと関連する方法
US8604023B2 (en) 2009-04-17 2013-12-10 The Regents Of The University Of Michigan 1,4-benzodiazepinone compounds and their use in treating cancer
US8673897B2 (en) 2009-09-18 2014-03-18 The Regents Of The University Of Michigan Benzodiazepinone compounds and methods of treatment using same
EP2501695B1 (en) 2009-11-17 2018-08-29 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
CN102753179A (zh) 2009-11-17 2012-10-24 密执安大学评议会 具有治疗性能的1,4-苯并二氮杂*-2,5-二酮和相关化合物
CA2923835C (en) * 2013-09-11 2022-11-29 The Administrators Of The Tulane Educational Fund Novel anthranilic amides and the use thereof

Also Published As

Publication number Publication date
IE32504B1 (en) 1973-08-22
IL31146A (en) 1972-04-27
IE32504L (en) 1969-05-24
BR6804236D0 (pt) 1973-02-08
FR1593335A (xx) 1970-05-25
DE1810423C3 (xx) 1973-10-11
DE1810423A1 (de) 1969-10-09
CH523265A (de) 1972-05-31
AT280290B (de) 1970-04-10
ES360410A1 (es) 1970-11-01
DK124950B (da) 1972-12-11
ES378977A1 (es) 1973-01-16
BE724364A (xx) 1969-05-22
SE356979B (xx) 1973-06-12
IL31146A0 (en) 1969-01-29
GB1173540A (en) 1969-12-10
FR8310M (xx) 1970-11-23
DE1810423B2 (de) 1973-03-22

Similar Documents

Publication Publication Date Title
AU425114B2 (xx)
AU416737B2 (xx)
AU2277767A (xx)
AU342066A (xx)
AU610966A (xx)
AU2528767A (xx)
AU2256867A (xx)
AU2116667A (xx)
AU3189468A (xx)
AU3151267A (xx)
AU2454867A (xx)
AU2977667A (xx)
BE692778A (xx)
BE514578A (xx)
AU3054676A (xx)
AU2406369A (xx)
AU23366A (xx)
AU1763766A (xx)
AU34866A (xx)
BE719199A (xx)
AU1677166A (xx)
BE477645A (xx)
AU459699A (xx)
BE709842A (xx)
BE711408A (xx)